Annual Report 2019

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2019 158 The United Laboratories International Holdings Limited Annual Report 2019 47. INFORMATION ABOUT THE STATEMENT OF FINANCIAL POSITION OF THE COMPANY (Continued) (b) Reserves Share premium Retained profits Total RMB’000 RMB’000 RMB’000 At 1 January 2018 2,356,763 1,467,813 3,824,576 Profit and total comprehensive income for the year – 187,916 187,916 Dividends recognised as distribution (Note 15) – (84,443) (84,443) Issue of shares upon conversion of convertible bonds (Note 32) 81,068 – 81,068 At 31 December 2018 2,437,831 1,571,286 4,009,117 Loss and total comprehensive expense for the year – (179,953) (179,953) Dividends recognised as distribution (Note 15) – (98,383) (98,383) Issue of shares upon conversion of convertible bonds (Note 32) 8,323 – 8,323 At 31 December 2019 2,446,154 1,292,950 3,739,104